drugset / Trial / NCT00931775

Citalopram Versus Citalopram Plus Pindolol in Major Depressive Disorder

NCT00931775

Phase 2 Completed 30 enrolled Sant Pau Research Institute
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to examine whether the speed of the clinical antidepressant action of citalopram can be accelerated by administering double doses of pindolol (15 mg/day, tid) which presumably should lead to increased 5-HT1A autoreceptor occupancy.

Timeline

Start
2002-12
Primary completion
2005-03
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Pindolol Small molecule 15 mg Oral